# Sodium nitroprusside

NDC: 70121-1189
Generic name: Sodium nitroprusside
Labeler / Manufacturer: Amneal Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20171107

FDA application: ANDA209493

## Active ingredients

- SODIUM NITROPRUSSIDE: 25 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70121-1189"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70121-1189
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2fa687a2-10e7-45ae-953a-9d63564c2908